FR2211469A1 - Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formed - Google Patents
Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formedInfo
- Publication number
- FR2211469A1 FR2211469A1 FR7245695A FR7245695A FR2211469A1 FR 2211469 A1 FR2211469 A1 FR 2211469A1 FR 7245695 A FR7245695 A FR 7245695A FR 7245695 A FR7245695 A FR 7245695A FR 2211469 A1 FR2211469 A1 FR 2211469A1
- Authority
- FR
- France
- Prior art keywords
- polyinhibitors
- pptn
- extraction
- treatment
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
Abstract
Enzymes are isolated from natural mixtures by treatment with a complex-forming polyinhibitor which is initially soluble in aq. organic media. The complex is separated and broken down by change in pH or ionic strength and the polyinhibitor may be recycled. Suitable polyinhibitors have a polymeric chain, e.g. a polyoxyalkylene glycol which is reacted with a polyfunctional derivative, and then with an inhibitor for the specific enzyme, e.g. D-phenyl alanine or D-trytophan for use with chymotrypsin. Pptn. of the complexes is effected at low temp. in aq. alcoholic media keeping the dielectric constant at 75-82. If desired the complex formation and extraction may be effected in series to isolate a series of enzymes from the mixture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7245695A FR2211469A1 (en) | 1972-12-21 | 1972-12-21 | Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7245695A FR2211469A1 (en) | 1972-12-21 | 1972-12-21 | Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formed |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2211469A1 true FR2211469A1 (en) | 1974-07-19 |
Family
ID=9109110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7245695A Withdrawn FR2211469A1 (en) | 1972-12-21 | 1972-12-21 | Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formed |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2211469A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0046915A2 (en) * | 1980-09-02 | 1982-03-10 | Gambro Lundia AB | A method for the recovery of a peptide-containing compound, and an apparatus for the realization of the method |
US6541629B1 (en) | 1999-09-10 | 2003-04-01 | The Procter & Gamble Company | Enzyme inhibitors |
US6723788B1 (en) | 1999-09-10 | 2004-04-20 | The Procter & Gamble Company | Enzyme inhibitors |
-
1972
- 1972-12-21 FR FR7245695A patent/FR2211469A1/en not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0046915A2 (en) * | 1980-09-02 | 1982-03-10 | Gambro Lundia AB | A method for the recovery of a peptide-containing compound, and an apparatus for the realization of the method |
EP0046915A3 (en) * | 1980-09-02 | 1982-06-09 | Gambro Lundia Ab | A method for the recovery of a peptide-containing compound, and a means for the realization of the method |
US6541629B1 (en) | 1999-09-10 | 2003-04-01 | The Procter & Gamble Company | Enzyme inhibitors |
US6723788B1 (en) | 1999-09-10 | 2004-04-20 | The Procter & Gamble Company | Enzyme inhibitors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU450763B2 (en) | Improved method and systeem for the collection, cultivation and identification of microorganisms from body fluid | |
AU465900B2 (en) | Coded identification card and method | |
CA1020397A (en) | Acid, pressure and heat treated vegetable protein | |
FR2211469A1 (en) | Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formed | |
CA959586A (en) | Process for the reduction of the biochemical oxygen demand of sewage, and for the recovery of the inherent protein | |
YU35553B (en) | Process for extracting phenol from sewage in the from of ureaformaldehyde-phenol condensates | |
ES439693A1 (en) | Treatment of malt to reduce stale flavor in beer | |
FR2299385A1 (en) | Anthocyan foodstuff colourings - obtd. from grape marc by treatment with anionic resin | |
FR2229388A1 (en) | Autostabilising seaweed by crushing with seawater - esp. to protect it from necrosis | |
AU3954672A (en) | Activated sludge sewage treatment process and system | |
FR2273067A1 (en) | Bacterial cell treatment - by autolysis in absence of added enzymes | |
FR2029701A1 (en) | Extraction of substances in low concentrate - ions in fluids by expanded polyurethane | |
CA1007587A (en) | Enzymatic treatment of protein mixtures containing orgotein | |
DK133952B (en) | Method for the extraction and purification of enzymes from microorganisms. | |
IE33303B1 (en) | Improvements in or relating to extraction processes | |
CA1017485A (en) | Process for preparation of sorbents suitable for the treatment of solutions containing high molecular substances, especially proteins | |
FR2194653A2 (en) | Biological water purification plant - water being subjected to bacterial treatment in chamber contg. rotating discs before aeration and sedimentation | |
FR2259060A1 (en) | Biological purification of effluent - esp contg phenolics and detergents using Trichosporon cutaneum | |
CA1009972A (en) | Water-soluble immunological adjuvants in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction | |
SU519508A1 (en) | Method of removing low molecular weight substances | |
FR2175287A5 (en) | Experimental flotation cell - testing small batches to establish parameters for ind treatment | |
CA880302A (en) | Method of extracting nucleic acid from activated sludge | |
AU485782B2 (en) | Sewage treatment plant and process | |
AU5292473A (en) | Method of treating timber | |
NL6912541A (en) | Production of uricase useful in treating gout |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |